Envoy Medical Warrant
COCHW
47 hedge funds and large institutions have $944K invested in Envoy Medical Warrant in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 11 closing their positions.
0.1% less ownership
Funds ownership: 40.34% → 40.24% (-0.1%)
13% less funds holding
Funds holding: 54 → 47 (-7)
33% less capital invested
Capital invested by funds: $1.4M → $944K (-$461K)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$19K |
| 2 |
CS
Clear Street
New York
|
+$16.3K |
| 3 |
Walleye Capital
New York
|
+$15.3K |
| 4 |
Walleye Trading
New York
|
+$11.5K |
| 5 |
VI
Vestcor Inc
Fredericton,
New Brunswick, Canada
|
+$11.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
-$856K |
| 2 |
SCM
Segantii Capital Management
Hong Kong
|
-$351K |
| 3 |
DC
Diametric Capital
Boston,
Massachusetts
|
-$18.5K |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$13.6K |
| 5 |
Man Group
London,
United Kingdom
|
-$5.03K |
COCHW Hedge Fund Activity: Q1 2024 in Review
47 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical Warrant (COCHW) for Q1 2024, worth a combined $944K — down 33% from $1.4M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of COCHW and 5 opened new positions — a net loss of 6 holders — while 9 trimmed existing stakes and 5 added.
The largest buyer was BNP Paribas Financial Markets, opening a new position worth an estimated $19K. The largest seller was Boothbay Fund Management, exiting entirely with an estimated $856K sold.
- 47 institutional investors held Envoy Medical Warrant (COCHW) as of Q1 2024, down from 54 in Q4 2023.
- Funds reported $944K of Envoy Medical Warrant stock for Q1 2024, down 33% quarter-over-quarter.
- 5 funds opened new Envoy Medical Warrant positions in Q1 2024 and 11 closed out, a net change of -6 holders.
- The largest Envoy Medical Warrant buyer in Q1 2024 was BNP Paribas Financial Markets, an estimated $19K added.
- The largest Envoy Medical Warrant seller in Q1 2024 was Boothbay Fund Management, an estimated $856K sold.
Based on aggregated 13F filings for Q1 2024.